The landscape of obesity treatment is changing rapidly. With more FDA-approved GLP-1 medications becoming available, people affected by obesity now have treatment options that were not accessible in the past. As costs decline and insurance coverage slowly expands, now is an important time to review your options and understand potential benefits. The Obesity Action Coalition
Read Article

FOR IMMEDIATE RELEASE November 4, 2025 At ObesityWeek 2025, new data show overwhelming public support for ensuring that all medications are evaluated and labeled for safety and efficacy in people with obesity. Atlanta, GA — New research presented today at ObesityWeek 2025, the world’s leading international conference on obesity science and care, shows that people
Read Article